Trial Profile
Multicenter, Randomized, Controlled, Double-Masked Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The RAINIER Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2022
Price :
$35
*
At a glance
- Drugs Simpinicline (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms The RAINIER
- Sponsors Oyster Point Pharmaceuticals
- 26 Oct 2018 Status changed from active, no longer recruiting to completed.
- 05 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Aug 2018 New trial record